Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[The mutation patterns of HBV P gene and genotyping in patients with lanivudine-resistant chronic hepatitis B].

Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology - 1 Oct 2011

Tang Jia-Liang, Zhou Jian-Kang

Abstract excerpt

OBJECTIVE: To analyze the mutation patters of HBV P gene and genotyping of heptitis B virus in patients with chronic hepatitis B (CHB) after the emergence of drug-resistance during lamivudine (LAM) therapy. METHODS: LAM-resistant mutations and genotype of HBV were dectected in patients with LAM-resistant CHB in our hospital from Sep. 2008 to June. 2010. RESULT: 107 patients had 8 mutation patterns. YMDD mutations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Gene Products, pol

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Lamivudine

Share to Young Adult

Source

Identifiers

PMID: 22338219

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[The mutation patterns of HBV P gene and genotyping in patients with lanivudine-resistant chronic hepatitis B].PMID 22338219Read ↗

[Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].Semantic proximity Read ↗

[Relationship between B virus hepatitis genotypes and therapeutic efficacy in early treatment for chronic hepatitis B by using lamivudine].Semantic proximity Read ↗

[Mutations of HBV polymerase gene sequence in lamivudine-resistant chronic hepatitis B patients].Semantic proximity Read ↗

[HBV gene variants and polymerse gene mutations in children with chronic hepatitis B in the course of the antiviral therapy].Semantic proximity Read ↗

Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment.Semantic proximity Read ↗

[Clinical and virologic characteristics of lamivudine resistance in HBV-associated chronic liver disease].Semantic proximity Read ↗

[Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation].Semantic proximity Read ↗

[Distribution of lamivudine- resistant variants in hepatitis B virus].Semantic proximity Read ↗

[Emergence and clinical significance of YMDD and HBeAg-related mutations during lamivudine treatment].Semantic proximity Read ↗

Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.Semantic proximity Read ↗

[Clinical efficacy of lamivudine in the treatment of chronic hepatitis B].Semantic proximity Read ↗

Hepatitis B virus genotypes and lamivudine resistance mutations in Jordan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.